Last 12 months
Inside the activity.
0 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2026 Filed Sep 21, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 20,750 | $0.00 Strike: $20.73 | $0.00 |
DisclosureSEC source: 0001193125-26-396711 · ownership.xml · derivative · entry 3 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,363 Underlying: Common stock; par value $0.00001 per share · 20,750 shares Expires 2027-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
SaleCommon stock, par value $0.00001 per share | 20,750 | $178.24 | $3,698,432.28 |
DisclosureSEC source: 0001193125-26-396711 · ownership.xml · nonDerivative · entry 2 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,444 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on January 30, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $174.55 to $180.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionCommon stock, par value $0.00001 per share | 20,750 | $20.73 | $430,147.50 |
DisclosureSEC source: 0001193125-26-396711 · ownership.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 327,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2026 Filed Aug 27, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 9,078 | $0.00 Strike: $20.73 | $0.00 |
DisclosureSEC source: 0001193125-26-371385 · ownership.xml · derivative · entry 6 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 166,113 Underlying: Common stock; par value $0.00001 per share · 9,078 shares Expires 2027-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F5 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F6 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023. Read SEC document |
| August 26, 2026 Filed Aug 27, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
SaleCommon stock, par value $0.00001 per share | 9,078 | $239.16 | $2,171,122.62 |
DisclosureSEC source: 0001193125-26-371385 · ownership.xml · nonDerivative · entry 4 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,444 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on January 30, 2026. F3 · price: This transaction was executed in multiple trades at prices ranging from $236.29 to $244.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| August 26, 2026 Filed Aug 27, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionCommon stock, par value $0.00001 per share | 9,078 | $20.73 | $188,186.94 |
DisclosureSEC source: 0001193125-26-371385 · ownership.xml · nonDerivative · entry 3 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 315,522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 9,491 | $0.00 Strike: $20.73 | $0.00 |
DisclosureSEC source: 0001193125-26-371385 · ownership.xml · derivative · entry 5 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,191 Underlying: Common stock; par value $0.00001 per share · 9,491 shares Expires 2027-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F5 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F6 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
SaleCommon stock, par value $0.00001 per share | 9,491 | $244.01 | $2,315,902.71 |
DisclosureSEC source: 0001193125-26-371385 · ownership.xml · nonDerivative · entry 2 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,444 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on January 30, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $241.46 to $251.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionCommon stock, par value $0.00001 per share | 9,491 | $20.73 | $196,748.43 |
DisclosureSEC source: 0001193125-26-371385 · ownership.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 315,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:30 UTC |
Veltre MariaDirector
|
GrantCommon stock, par value $0.00001 per share | 772 | $0.00 | $0.00 |
DisclosureSEC source: 0001752243-26-000006 · ownership.xml · nonDerivative · entry 1 Veltre Maria · CIK 0001752243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 772 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on August 5, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:30 UTC |
Chartier KirkChief Strategy Officer
|
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 2,095 | $0.00 Strike: $257.79 | $0.00 |
DisclosureSEC source: 0001483333-26-000002 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,095 Underlying: Common stock; par value $0.00001 per share · 2,095 shares Expires 2033-08-05 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 6,190 | $0.00 Strike: $257.79 | $0.00 |
DisclosureSEC source: 0001315224-26-000004 · ownership.xml · derivative · entry 1 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,190 Underlying: Common stock; par value $0.00001 per share · 6,190 shares Expires 2033-08-05 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:30 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 1,453 | $0.00 Strike: $257.79 | $0.00 |
DisclosureSEC source: 0001621195-26-000002 · ownership.xml · derivative · entry 1 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,453 Underlying: Common stock; par value $0.00001 per share · 1,453 shares Expires 2033-08-05 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:30 UTC |
Cunningham Steven EDirector · Chief Executive Officer
|
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 7,359 | $0.00 Strike: $257.79 | $0.00 |
DisclosureSEC source: 0001575452-26-000002 · ownership.xml · derivative · entry 1 Cunningham Steven E · CIK 0001575452 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,359 Underlying: Common stock; par value $0.00001 per share · 7,359 shares Expires 2033-08-05 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:30 UTC |
Cornelis ScottChief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 1,500 | $0.00 Strike: $257.79 | $0.00 |
DisclosureSEC source: 0002104070-26-000005 · ownership.xml · derivative · entry 1 Cornelis Scott · CIK 0002104070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common stock; par value $0.00001 per share · 1,500 shares Expires 2033-08-05 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 11,494 | $0.00 Strike: $20.73 | $0.00 |
DisclosureSEC source: 0001315224-26-000002 · ownership.xml · derivative · entry 6 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 184,682 Underlying: Common stock; par value $0.00001 per share · 11,494 shares Expires 2027-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
SaleCommon stock, par value $0.00001 per share | 11,494 | $231.45 | $2,660,332.28 |
DisclosureSEC source: 0001315224-26-000002 · ownership.xml · nonDerivative · entry 4 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,444 F2 · price: This transaction was executed in multiple trades at prices ranging from $225.64 to $235.4298. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionCommon stock, par value $0.00001 per share | 11,494 | $20.73 | $238,270.62 |
DisclosureSEC source: 0001315224-26-000002 · ownership.xml · nonDerivative · entry 3 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 317,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2026 Filed Jul 16, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 17,006 | $0.00 Strike: $20.73 | $0.00 |
DisclosureSEC source: 0001315224-26-000002 · ownership.xml · derivative · entry 5 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 196,176 Underlying: Common stock; par value $0.00001 per share · 17,006 shares Expires 2027-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023. Read SEC document |
| July 14, 2026 Filed Jul 16, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
SaleCommon stock, par value $0.00001 per share | 17,006 | $231.51 | $3,936,992.74 |
DisclosureSEC source: 0001315224-26-000002 · ownership.xml · nonDerivative · entry 2 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,444 F1 · price: This transaction was executed in multiple trades at prices ranging from $229.9452 to $233.6532. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| July 14, 2026 Filed Jul 16, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionCommon stock, par value $0.00001 per share | 17,006 | $20.73 | $352,534.38 |
DisclosureSEC source: 0001315224-26-000002 · ownership.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 323,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 20:30 UTC |
TEBBE MARKDirector
|
SaleCommon stock, par value $0.00001 per share | 20,000 | $201.37 | $4,027,360.00 |
DisclosureSEC source: 0001193125-26-279537 · ownership.xml · nonDerivative · entry 1 TEBBE MARK · CIK 0001131785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,029 F1 · price: This transaction was executed in multiple trades at prices ranging from $200.325 to $202.26. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 33,060 | $0.00 Strike: $20.73 | $0.00 |
DisclosureSEC source: 0001193125-26-277580 · ownership.xml · derivative · entry 3 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,182 Underlying: Common stock; par value $0.00001 per share · 33,060 shares Expires 2027-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
SaleCommon stock, par value $0.00001 per share | 33,060 | $199.05 | $6,580,639.28 |
DisclosureSEC source: 0001193125-26-277580 · ownership.xml · nonDerivative · entry 2 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,444 F1 · price: This transaction was executed in multiple trades at prices ranging from $193.85 to $202.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionCommon stock, par value $0.00001 per share | 33,060 | $20.73 | $685,333.80 |
DisclosureSEC source: 0001193125-26-277580 · ownership.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 339,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2026 Filed Jun 16, 2026 20:30 UTC |
GOODYEAR WILLIAM MDirector
|
SaleCommon stock, par value $0.00001 per share | 3,500 | $188.02 | $658,054.95 |
DisclosureSEC source: 0001193125-26-272696 · ownership.xml · nonDerivative · entry 2 GOODYEAR WILLIAM M · CIK 0001115909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,820 F1 · price: This transaction was executed in multiple trades at prices ranging from $186.53 to $190.17. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:30 UTC |
GOODYEAR WILLIAM MDirector
|
GiftCommon stock, par value $0.00001 per share | 8,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-272696 · ownership.xml · nonDerivative · entry 1 GOODYEAR WILLIAM M · CIK 0001115909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,320 Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
GOODYEAR WILLIAM MDirector
|
SaleCommon stock, par value $0.00001 per share | 5,983 | $163.13 | $975,999.01 |
DisclosureSEC source: 0001193125-26-255557 · ownership.xml · nonDerivative · entry 1 GOODYEAR WILLIAM M · CIK 0001115909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,757 F1 · price: This transaction was executed in multiple trades at prices ranging from $161.28 to $164.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:30 UTC |
RICE LINDA JOHNSONDirector
|
SaleCommon stock, par value $0.00001 per share | 1,300 | $161.20 | $209,555.84 |
DisclosureSEC source: 0001193125-26-253599 · ownership.xml · nonDerivative · entry 1 RICE LINDA JOHNSON · CIK 0001188735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,277 F1 · price: This transaction was executed in multiple trades at prices ranging from $161.1102 to $161.47. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| May 22, 2026 Filed May 26, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 3,076 | $0.00 Strike: $20.73 | $0.00 |
DisclosureSEC source: 0001193125-26-239437 · ownership.xml · derivative · entry 6 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 246,242 Underlying: Common stock; par value $0.00001 per share · 3,076 shares Expires 2027-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023. Read SEC document |
| May 22, 2026 Filed May 26, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
SaleCommon stock, par value $0.00001 per share | 3,076 | $158.45 | $487,382.05 |
DisclosureSEC source: 0001193125-26-239437 · ownership.xml · nonDerivative · entry 4 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,444 F2 · price: This transaction was executed in multiple trades at prices ranging from $157.50 to $161.24. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| May 22, 2026 Filed May 26, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionCommon stock, par value $0.00001 per share | 3,076 | $20.73 | $63,765.48 |
DisclosureSEC source: 0001193125-26-239437 · ownership.xml · nonDerivative · entry 3 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 309,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 7,180 | $0.00 Strike: $20.73 | $0.00 |
DisclosureSEC source: 0001193125-26-239437 · ownership.xml · derivative · entry 5 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 249,318 Underlying: Common stock; par value $0.00001 per share · 7,180 shares Expires 2027-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
SaleCommon stock, par value $0.00001 per share | 7,180 | $160.37 | $1,151,473.83 |
DisclosureSEC source: 0001193125-26-239437 · ownership.xml · nonDerivative · entry 2 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,444 F1 · price: This transaction was executed in multiple trades at prices ranging from $158.16 to $162.90. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
Exercise / conversionCommon stock, par value $0.00001 per share | 7,180 | $20.73 | $148,841.40 |
DisclosureSEC source: 0001193125-26-239437 · ownership.xml · nonDerivative · entry 1 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 313,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:30 UTC |
GOODYEAR WILLIAM MDirector
|
SaleCommon stock, par value $0.00001 per share | 6,231 | $166.08 | $1,034,829.53 |
DisclosureSEC source: 0001193125-26-232704 · ownership.xml · nonDerivative · entry 1 GOODYEAR WILLIAM M · CIK 0001115909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,740 F1 · price: This transaction was executed in multiple trades at prices ranging from $165.60 to $167.235. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
CARNAHAN ELLENDirector
|
GrantCommon stock, par value $0.00001 per share | 1,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-226923 · ownership.xml · nonDerivative · entry 1 CARNAHAN ELLEN · CIK 0001037175 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,704 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
GOODYEAR WILLIAM MDirector
|
GrantCommon stock, par value $0.00001 per share | 1,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-226943 · ownership.xml · nonDerivative · entry 1 GOODYEAR WILLIAM M · CIK 0001115909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,971 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
TEBBE MARKDirector
|
GrantCommon stock, par value $0.00001 per share | 1,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-226933 · ownership.xml · nonDerivative · entry 1 TEBBE MARK · CIK 0001131785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,029 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
Chartier KirkChief Strategy Officer
|
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 3,038 | $0.00 Strike: $166.88 | $0.00 |
DisclosureSEC source: 0001193125-26-226928 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,038 Underlying: Common stock; par value $0.00001 per share · 3,038 shares Expires 2033-05-13 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
McGowan MarkDirector
|
GrantCommon stock, par value $0.00001 per share | 1,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-226940 · ownership.xml · nonDerivative · entry 1 McGowan Mark · CIK 0001482192 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,021 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
KAPLAN GREGG A.Director
|
GrantCommon stock, par value $0.00001 per share | 1,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-226944 · ownership.xml · nonDerivative · entry 1 KAPLAN GREGG A. · CIK 0001461299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,232 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
FEEHAN DANIEL RDirector
|
GrantCommon stock, par value $0.00001 per share | 1,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-226924 · ownership.xml · nonDerivative · entry 1 FEEHAN DANIEL R · CIK 0001188234 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,706 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
RICE LINDA JOHNSONDirector
|
GrantCommon stock, par value $0.00001 per share | 1,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-226941 · ownership.xml · nonDerivative · entry 1 RICE LINDA JOHNSON · CIK 0001188735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,577 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
Fisher DavidDirector · Executive Chairman
|
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 8,979 | $0.00 Strike: $166.88 | $0.00 |
DisclosureSEC source: 0001193125-26-226934 · ownership.xml · derivative · entry 1 Fisher David · CIK 0001315224 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,979 Underlying: Common stock; par value $0.00001 per share · 8,979 shares Expires 2033-05-13 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
Gray James ADirector
|
GrantCommon stock, par value $0.00001 per share | 1,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-226945 · ownership.xml · nonDerivative · entry 1 Gray James A · CIK 0001315492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,029 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:33 UTC |
Cornelis ScottChief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 2,176 | $0.00 Strike: $166.88 | $0.00 |
DisclosureSEC source: 0001193125-26-226985 · ownership.xml · derivative · entry 2 Cornelis Scott · CIK 0002104070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,176 Underlying: Common stock; par value $0.00001 per share · 2,176 shares Expires 2033-05-13 F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
Corby Lindsay YDirector
|
GrantCommon stock, par value $0.00001 per share | 1,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-226931 · ownership.xml · nonDerivative · entry 1 Corby Lindsay Y · CIK 0001557298 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,660 F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 13, 2027, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
Cunningham Steven EDirector · Chief Executive Officer
|
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 10,674 | $0.00 Strike: $166.88 | $0.00 |
DisclosureSEC source: 0001193125-26-226927 · ownership.xml · derivative · entry 1 Cunningham Steven E · CIK 0001575452 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,674 Underlying: Common stock; par value $0.00001 per share · 10,674 shares Expires 2033-05-13 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC |
Rahilly SeanGeneral Counsel and Secretary
|
GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 2,108 | $0.00 Strike: $166.88 | $0.00 |
DisclosureSEC source: 0001193125-26-226922 · ownership.xml · derivative · entry 1 Rahilly Sean · CIK 0001621195 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,108 Underlying: Common stock; par value $0.00001 per share · 2,108 shares Expires 2033-05-13 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.